Skip to menu Skip to content Skip to footer

2025

Conference Publication

Transfusion-dependence predicts poor outcomes following hyperbaric oxygen treatment for radiation cystitis: a single tertiary centre retrospective analysis

Joshi, Sachin, Loganathan, Ajanthan, Dunglison, Nigel, Esler, Rachel, Martin, Benjamin, Llewellyn, Stacey, Thistlethwaite, Kenneth and Roberts, Matthew (2025). Transfusion-dependence predicts poor outcomes following hyperbaric oxygen treatment for radiation cystitis: a single tertiary centre retrospective analysis. USANZ 77th Annual Scientific Meeting, Perth, WA, Australia, 1-4 March 2025. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Transfusion-dependence predicts poor outcomes following hyperbaric oxygen treatment for radiation cystitis: a single tertiary centre retrospective analysis

2025

Journal Article

Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterials

Lim, Malcom, Simpson, Peter T., Lakhani, Sunil R., Masud, Mostafa, Puttick, Simon, Rose, Stephen, Roberts, Matthew J. and Koo, Kevin M. (2025). Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterials. ChemNanoMat, 11 (1) e202400449. doi: 10.1002/cnma.202400449

Clinically boosting cancer molecular targeted radioligand therapies with innovative nanomaterials

2025

Journal Article

Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories

Aziz, Moez Karim, Molony, Donald, Monlezun, Dominique, Holder, Travis, Brunckhorst, Oliver, Higgason, Noel, Roland, Jerry, Magill, Resa, Fatakdawala, Mariya, Iacobucci, Alexander, Mody-Bailey, Neal, Owen, Chris, Zarker, Andrew, Thames, Emma, Swaby, Justin, Xiao, Daniel, Choi, Lily, Desai, Shubh, Galan, Jacob, Deng, Brett, Hartshorne, Taylor, Nichols, Alexis, Zhang, Allan, Imber, Jared, Song, Jeffrey, Jones, William, Rivas, Alexis, Sanchez, Darren, Guhan, Maya ... European Association of Urology Prostate Cancer Guidelines Panel (2025). Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories. European Urology, 87 (1), 15-26. doi: 10.1016/j.eururo.2024.08.031

Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories

2025

Journal Article

Pelvic Lymph Node Dissection in Prostate Cancer: Evidence and Implications

Roberts, Matthew J., Gandaglia, Giorgio, Oprea-Lager, Daniela E., Stranne, Johan, Cornford, Philip and Tilki, Derya (2025). Pelvic Lymph Node Dissection in Prostate Cancer: Evidence and Implications. European Urology, 87 (6), 619-621. doi: 10.1016/j.eururo.2025.03.004

Pelvic Lymph Node Dissection in Prostate Cancer: Evidence and Implications

2024

Journal Article

Intra-individual comparisons of [18F]fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in prostate cancer patients across different disease states: new insights into disease heterogeneity

McGeorge, Stephen, Pattison, David A., Dhiantravan, Nattakorn, Thomas, Paul A., Yaxley, John W. and Roberts, Matthew J. (2024). Intra-individual comparisons of [18F]fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in prostate cancer patients across different disease states: new insights into disease heterogeneity. Uro, 5 (1), 1-11. doi: 10.3390/uro5010001

Intra-individual comparisons of [18F]fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in prostate cancer patients across different disease states: new insights into disease heterogeneity

2024

Journal Article

Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach

Collin, Harry, Roberts, Matthew J., Keogh, Kandice, Siriwardana, Amila and Basto, Marnique (2024). Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach. BJUI Compass, 6 (1) e427, e427. doi: 10.1002/bco2.427

Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach

2024

Journal Article

A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware

Mehawed, Georges, Roberts, Matthew J., Bugeja, Jessica, Dowling, Jason, Stewart, Kate, Gunasena, Rivindi, Malczewski, Frances, Rukin, Nicholas J. and Murray, Rebecca (2024). A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware. Journal of Clinical Medicine, 13 (23) 7384, 1-11. doi: 10.3390/jcm13237384

A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware

2024

Journal Article

Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics

Roberts, Matthew J., Papa, Nathan, Veerman, Hans, de Bie, Katelijne, Morton, Andrew, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Donswijk, Maarten L., van der Poel, Henk G., Samaratunga, Hemamali, Wong, David, Brown, Nicholas, Parkinson, Robert, Gianduzzo, Troy, Kua, Boon, Coughlin, Geoffrey D., Oprea‐Lager, Daniela E., Emmett, Louise, van Leeuwen, Pim J., Yaxley, John W. and Vis, André N. (2024). Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics. BJU International, 134 (S2), 47-55. doi: 10.1111/bju.16482

Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics

2024

Conference Publication

The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

Teppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L. and Tuffaha, H. (2024). The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17-20 November 2024. New York, United States: Elsevier. doi: 10.1016/j.jval.2024.10.610

The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

2024

Conference Publication

The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons.

The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

2024

Journal Article

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

2024

Journal Article

The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort

Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Pelecanos, Anita, Gan, Chun Loo, Goh, Jeffrey C., Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2024). The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort. European Urology Focus, 10 (5), 770-778. doi: 10.1016/j.euf.2023.12.004

The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort

2024

Journal Article

Beyond prostate imaging reporting and data system: combining magnetic resonance imaging prostate imaging reporting and data system and prostate-specific membrane antigen-positron emission tomography/computed tomography primary score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer

Emmett, Louise, Papa, Nathan, Hope, Thomas A., Fendler, Wolfgang, Calais, Jeremie, Burger, Irene, Eiber, Matthias, Barbato, Francesco, Moon, Daniel, Counter, William, John, Nikeith, Xue, Alan, Franklin, Anthony, Thompson, James, Rasiah, Kris, Frydenberg, Mark, Yaxley, John, Buteau, James, Agrawal, Shikha, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Woo, Henry, Hsiao, Edward, Sutherland, Thomas, Perry, Elyse, Stricker, Phillip, Hofman, Michael S. ... Murphy, Declan (2024). Beyond prostate imaging reporting and data system: combining magnetic resonance imaging prostate imaging reporting and data system and prostate-specific membrane antigen-positron emission tomography/computed tomography primary score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer. The Journal of Urology, 212 (2), 299-309. doi: 10.1097/JU.0000000000004010

Beyond prostate imaging reporting and data system: combining magnetic resonance imaging prostate imaging reporting and data system and prostate-specific membrane antigen-positron emission tomography/computed tomography primary score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer

2024

Journal Article

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: screening, diagnosis, and local treatment with curative intent

Cornford, Philip, van den Bergh, Roderick C.N., Briers, Erik, Van den Broeck, Thomas, Brunckhorst, Oliver, Darraugh, Julie, Eberli, Daniel, De Meerleer, Gert, De Santis, Maria, Farolfi, Andrea, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., Lardas, Michael, van Leenders, Geert J.L.H., Liew, Matthew, Linares Espinos, Estefania, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Ploussard, Guillaume, Roberts, Matthew J., Rouvière, Olivier, Schoots, Ivo G., Schouten, Natasha, Smith, Emma J., Stranne, Johan, Wiegel, Thomas ... Tilki, Derya (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: screening, diagnosis, and local treatment with curative intent. European Urology, 86 (2), 148-163. doi: 10.1016/j.eururo.2024.03.027

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: screening, diagnosis, and local treatment with curative intent

2024

Journal Article

Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care

Lindsay, Daniel, Schofield, Penelope, Roberts, Matthew J., Yaxley, John, Quinn, Stephen, Richards, Natalie, Frydenberg, Mark, Gardiner, Robert, Lawrentschuk, Nathan, Juraskova, Ilona, Murphy, Declan G. and Collins, Louisa G. (2024). Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care. European Urology Oncology, 8 (3), 674-680. doi: 10.1016/j.euo.2024.08.005

Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care

2024

Journal Article

ChatGPT can help guide and empower patients after prostate cancer diagnosis

Collin, Harry, Keogh, Kandice, Basto, Marnique, Loeb, Stacy and Roberts, Matthew J. (2024). ChatGPT can help guide and empower patients after prostate cancer diagnosis. Prostate Cancer and Prostatic Diseases, 28 (2) 87, 513-515. doi: 10.1038/s41391-024-00864-6

ChatGPT can help guide and empower patients after prostate cancer diagnosis

2024

Journal Article

Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

Buteau, James P., Moon, Daniel, Fahey, Michael T., Roberts, Matthew J., Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, De Abreu Lourenco, Richard, Dhillon, Haryana M., Kasivisvanathan, Veeru, Francis, Roslyn J., Stricker, Phillip, Agrawal, Shihka, O'Brien, Jonathan, McVey, Aoife, Sharma, Gaurav, Levy, Sidney, Ayati, Narjess, Nguyen, Andrew, Lee, Su-Faye, Pattison, David A., Sivaratnam, Dinesh, Frydenberg, Mark, Du, Yang, Titus, Jehan, Lee, Sze-Ting, Ischia, Joseph, Jack, Greg ... Emmett, Louise (2024). Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer. European Urology Oncology, 7 (3), 544-552. doi: 10.1016/j.euo.2023.11.008

Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer

2024

Journal Article

Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more

Mehawed, Georges, Murray, Rebecca, Wang, Kevin, Roberts, Matthew J. and Rukin, Nicholas J. (2024). Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more. BJU International, 134 (S2), 14-16. doi: 10.1111/bju.16374

Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more

2024

Journal Article

What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies

Wynn, Jessica, Homewood, David, Tse, Vincent, Fong, Eva, Roberts, Matthew J., Chung, Eric and Dowling, Caroline (2024). What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies. Australian Journal of General Practice, 53 (5), 265-273. doi: 10.31128/AJGP-10-23-7004

What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies

2024

Journal Article

Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study

Roberts, Natasha A., Esler, Rachel, Pearce, Adam, Wyld, David, Smith, Michael, Woollett, Kaylene, Mazariego, Carolyn and Roberts, Matthew J. (2024). Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study. European Urology Open Science, 62, 36-42. doi: 10.1016/j.euros.2024.01.018

Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study